5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole,
AN-2728,
AN2728,
crisaborole,
906673-24-3,
Crisaborole,
AN-2728,
AN2728,
4-((1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile,
Eucrisa,
AN 2728,
UNII-Q2R47HGR7P,
Crisaborole topical ointment 2%,
5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole,
Q2R47HGR7P,
CHEMBL484785,
AK102641,
4-((1-HYDROXY-1,3-DIHYDROBENZO-[C][1,2]OXABOROL-5-YL)OXY)BENZONITRILE,
4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile,
Benzonitrile, 4-((1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy)-,
Benzonitrile, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-,
Eucrisa (TN),
crisaborole-an2728,
Crisaborole (AN2728),
Crisaborole (USAN/INN),
Crisaborole [USAN:INN],
Crisaborole(AN-2728),
SCHEMBL595261,
C14H10BNO3,
GTPL9151,
Crisaborole, >=98% (HPLC),
CTK8C0958,
DTXSID10238231,
CHEBI:134677,
USZAGAREISWJDP-UHFFFAOYSA-N,
BCP08677,
EX-A1087,
5098AC,
ABP001114,
ANW-65536,
BDBM50277665,
MFCD17169940,
4-((1-Hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-6-yl)oxy)benzonitrile,
AKOS016005425,
ZINC169748244,
API0013781,
CS-1057,
DB05219,
SB16802,
compound 5b [PMID: 19303290],
KS-0000063U,
NCGC00345792-01,
NCGC00345792-02,
AC-30331,
BC245091,
HY-10978,
AX8234180,
DB-078771,
TC-154281,
FT-0767999,
ST24042710,
D10873,
W-5676,
5-(4-cyanophenoxy)-1-hydroxy-2,1-benzoxaborole,
4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile,
4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile,
4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzonitrile,
Crisaborole [USAN],
D0SM0W,
ACN-054112,
A12776,